Full Text
Has Pharmaceutical Innovation Increased Persistence and Adherence of Multiple Sclerosis Patients in Germany?

Abstract

Authors

KE Fischer S Frey F Lichtenberg

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×